More than 33 million Americans have received at least one dose of a Covid-19 vaccine from Pfizer/BioNtech or Moderna. Johnson & Johnson’s vaccine candidate could receive an emergency use authorization in the coming weeks. CNN Chief Medical Correspondent Dr. Sanjay Gupta is optimistic, and he’s going to tell you why.
To learn more about how CNN protects list ... Show More
Yesterday
The Next Breakthrough Addiction Treatment May Be Here
The diabetes drugs that transformed weight loss may be key to treating addiction, too. Dr. Sanjay Gupta speaks with Dr. Dhruv Khullar about how GLP-1s affect the brain, its reward system, and maybe even addiction. This episode was produced by Jennifer Lai with assistance from Sof ... Show More
29m 14s
Jul 24
When Snoring Becomes a Danger to Your Health
Dr. Sanjay Gupta talks with Dr. Paul Hoff, an Ear, Nose and Throat specialist (otolaryngologist) at the University of Michigan, about why sleep apnea is often missed, how it can harm the body and mind, and the latest treatment options. This episode was produced by Madeleine Thomp ... Show More
27m 18s
Feb 2021
U.S. closer to first single-dose vaccine after Johnson & Johnson version clears major FDA hurdle; Dem divide on Biden OMB nominee, push for $15 minimum wage; Sheriff: Woods’ survival from crash “nothing short of a miracle”; First interview with Biden’s Veterans Affairs Secretary
Promising signs in pandemic: vaccine progress, cases and hospitalizations down, deaths slow in new estimate; WH: 3-4 million doses of J&J vaccine to go out next week if FDA grants emergency use; Moderna testing vaccine boosters to combat South Africa variant; WH: J&J’s production ... Show More
44m 36s